๐ฐ Denisea Yardley News
Denisea Yardley News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Denisea Yardley. Real-time updates on events, politics, business and more.
June 1, 2024
The addition of ribociclib (Kisqali; Novartis) to endocrine therapy demonstrated a 28% risk reduction in invasive disease-free survival.
June 16, 2023
Nearly 60% of health care providers surveyed failed to choose the same treatment strategies for HER2โearly breast cancer.
September 11, 2022
Basel: Pharma major, Novartis, has announced results from a new pooled exploratory analysis across the entire MONALEESA Phase III program, confirming nearly one year of additional overall survival...
September 9, 2022
New large pooled exploratory analysis from MONALEESA-2, -3 and -7 reinforces unparalleled overall survival (OS) benefit of Kisqali plus ET compared to